An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film...
Children's National Medical Center, Washington, District of Columbia, United States
State Institution B.B. Petrovsky Russian Research Centre of Surgery of RAMS, 2, Abrikosovsky per., Moscow, Russian Federation
Medical Academy of Postgraduate Study, 41, ulica Kirochnaya,, St. Petersburg, Russian Federation
Westfries Gasthuis, Department Intensieve Zorgen, Maelsonstraat 3,, Hoorn, Netherlands
UMDNJ University Hospital, Newark, New Jersey, United States
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Baylor University Medical Center, Dallas, Texas, United States
Cardiothoracic and Vascular Surgical Specialists, Columbus, Ohio, United States
University of California, San Francisco, San Francisco, California, United States
Pediatric Sedation Unit, Wesley Medical Center, Wichita, Kansas, United States
LAC-USC Medical Center Los Angeles, Los Angeles, California, United States
Parkland Health and Hospital System, Dallas, Texas, United States
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
Stanford University Medical Center, Stanford, California, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Southern Arizona VA Healthcare System, Tucson, Arizona, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.